Home/Filings/4/0001062993-25-011425
4//SEC Filing

Freund John Gordon 4

Accession 0001062993-25-011425

CIK 0001267565other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:04 PM ET

Size

11.0 KB

Accession

0001062993-25-011425

Insider Transaction Report

Form 4
Period: 2025-06-09
Transactions
  • Exercise/Conversion

    Common Stock

    2025-06-09$13.45/sh+15,000$201,75077,259 total
  • Exercise/Conversion

    Stock Option (Right to Purchase)

    2025-06-0915,0000 total
    Exercise: $13.45Exp: 2025-09-10Common Stock (15,000 underlying)
  • Sale

    Common Stock

    2025-06-09$30.62/sh6,601$202,14970,658 total
Holdings
  • Common Stock

    (indirect: By LLC)
    8,625
  • Common Stock

    (indirect: By Partnership)
    34,788
Footnotes (4)
  • [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.62 to $30.628, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The shares are held by Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC. The reporting person disclaims beneficial ownership of all the shares held by Skyline Venture Management V, LLC except to the extent of his proportionate pecuniary interest therein.
  • [F3]The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.
  • [F4]The option is fully vested and exercisable.

Issuer

COLLEGIUM PHARMACEUTICAL, INC

CIK 0001267565

Entity typeother

Related Parties

1
  • filerCIK 0001296771

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:04 PM ET
Size
11.0 KB